Log in
/
English
Polski
Español
українська
Toggle navigation
Textbook
Sections
Diseases
Noninvasive Diagnostic Tests
Procedures
Signs and Symptoms
Trauma and Injuries
Acute and Critical Medical Care
Abbreviations
CME
GRADE
Chapters
Course
What’s New
Interviews
McMaster Perspective
Cardiology
Endocrinology
Gastroenterology
Hematology
ICU & Emergencies
Infectious Diseases
Nephrology
Neurology
Oncology
Respirology
Rheumatology
Toxicology
VTE
Other
Lectures
Refreshers
Articles
Resources
Editorial Board
Mobile
Sponsors
Diseases
Allergy & Immunology
Cardiovascular Diseases
Dermatology
Endocrinology
Fluids, Electrolytes, Acids, Bases
Gastroenterology
Geriatrics
Hematology
Infectious Diseases
Nephrology
Neurology
Palliative Care
Poisonings & Intoxications
Psychiatry
Respiratory Diseases
Rheumatology
Noninvasive Diagnostic Tests
Procedures
Signs & Symptoms
Trauma & Injuries
Acute & Critical Medical Care
Abbreviations
CME
GRADE
Log in
/
McMaster Textbook of Internal Medicine
Interviews
VTE
Evidence suggesting benefits of D-dimer monitoring in patients with cancer or chronic diseases
Evidence suggesting benefits of D-dimer monitoring in patients with cancer or chronic diseases
2015-06-05
Mark Crowther
See also
Differences in risk stratification, prophylaxis, and treatment of thrombosis in patients with cancer vs patients with nonneoplastic diseases
Are there any important differences in risk stratification, prophylaxis, and treatment of thrombosis in patients with cancer vs patients with nonneoplastic diseases?
Evidence for the use of aspirin in primary and secondary prophylaxis of venous thrombosis
The role of aspirin in prophylaxis of venous thrombosis is being reevaluated every few years. What is the evidence for the use of aspirin in primary and secondary prophylaxis of venous thrombosis?
We would love to hear from you
Comments, mistakes, suggestions?
Send feedback
Social Media